VistaGen Therapeutics Future Growth

How is VistaGen Therapeutics forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?

Future Growth Score

5/6

Future Growth Score 5/6

66.2%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

NasdaqCM:VTGN - Analysts future estimates and past financials data (USD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
3/31/2025	76	-28	N/A	N/A	2
3/31/2024	1	-65	N/A	N/A	1
3/31/2023	0	-65	N/A	N/A	2
9/30/2022	0	-65	-60	-60	N/A
6/30/2022	1	-60	-55	-55	N/A
3/31/2022	1	-49	-45	-45	N/A
12/31/2021	2	-62	-35	-35	N/A
9/30/2021	1	-56	-28	-28	N/A
6/30/2021	1	-47	-16	-15	N/A
3/31/2021	1	-42	-12	-12	N/A
12/31/2020	1	-16	-10	-9	N/A
9/30/2020	0	-17	-9	-9	N/A
6/30/2020	N/A	-19	-14	-14	N/A
3/31/2020	N/A	-22	-16	-16	N/A
12/31/2019	N/A	-24	-17	-17	N/A
9/30/2019	N/A	-26	-16	-16	N/A
6/30/2019	N/A	-28	-16	-16	N/A
3/31/2019	N/A	-26	-15	-15	N/A
12/31/2018	N/A	-24	-14	-14	N/A
9/30/2018	N/A	-20	-12	-12	N/A
6/30/2018	N/A	-18	-10	-10	N/A
3/31/2018	N/A	-16	-9	-9	N/A
12/31/2017	N/A	-14	-8	-8	N/A
9/30/2017	1	-13	-8	-7	N/A
6/30/2017	1	-12	-8	-8	N/A
3/31/2017	1	-12	-8	-7	N/A
12/31/2016	1	-18	-7	-7	N/A
9/30/2016	N/A	-19	-6	-6	N/A
6/30/2016	N/A	-24	N/A	-6	N/A

Earnings vs Savings Rate: VTGN is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2%).

Earnings vs Market: VTGN is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: VTGN is expected to become profitable in the next 3 years.

Revenue vs Market: VTGN's revenue (71.2% per year) is forecast to grow faster than the US market (6.9% per year).

High Growth Revenue: VTGN's revenue (71.2% per year) is forecast to grow faster than 20% per year.

Future ROE: Insufficient data to determine if VTGN's Return on Equity is forecast to be high in 3 years time